Cancer surveillance in adults with germline TP53 pathogenic variants: A single-center observational study.

Authors

null

Thomas Meyskens

Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium

Thomas Meyskens , Vincent Vandecaveye , Steven Pans , Raphaëla Dresen , Chantal Van Ongeval , Ann Smeets , Ines Nevelsteen , Patrick Neven , Hans Wildiers , Patrick Schoffski , Ellen Denayer , Griet Van Buggenhout , Geneviève Michils , Hilde Brems , Eric Legius , Kevin Punie

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Prevention, Risk Reduction, and Hereditary Cancer

Track

Prevention, Risk Reduction, and Genetics

Sub Track

Cancer Genetics

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 10530)

DOI

10.1200/JCO.2021.39.15_suppl.10530

Abstract #

10530

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Helen Mackay

First Author: Bita Nehoray

Poster

2020 ASCO Virtual Scientific Program

Clinical conundrums: Developing a strategy for discerning TP53-associated chip and coherent clinical care.

Clinical conundrums: Developing a strategy for discerning TP53-associated chip and coherent clinical care.

First Author: Jeffrey N. Weitzel

First Author: Jennifer Yeh